How to apply for NMPA registration for medical devices in China?
Release time:2024-07-23 14:03:48 The author: source:
Classification of Your Device: Determine the classification of your medical device according to China's classification rules (Class I, II, or III). This classification will determine the applicable regulatory requirements.

Applying for NMPA (National Medical Products Administration) registration for medical devices in China involves several key steps and requirements. Here’s a general overview of the process:

  1. Classification of Your Device: Determine the classification of your medical device according to China's classification rules (Class I, II, or III). This classification will determine the applicable regulatory requirements.

  2. Local Representative: If you are a foreign manufacturer, appoint a local representative or agent in China. This representative will liaise with the NMPA on your behalf.

  3. Technical Documentation Preparation: Prepare technical documentation, including:

    • Device description and specifications
    • Design and manufacturing information
    • Risk analysis and mitigation measures
    • Testing and validation data
    • Clinical evaluation data (if required)
    • Labeling and Instructions for Use (IFU)
  4. Quality Management System: Implement a Quality Management System (QMS) compliant with NMPA requirements. This may involve obtaining ISO 13485 certification.

  5. Clinical Evaluation (if required): For higher-risk devices, clinical evaluation data may be required to demonstrate safety and efficacy.

  6. Application Submission: Submit your application through the NMPA's online platform or through your local representative. Include all required documentation and pay the application fees.

  7. Review and Approval: The NMPA will review your application and technical documentation. They may conduct inspections or request additional information during the review process.

  8. Post-Market Surveillance: After obtaining registration, comply with post-market surveillance requirements, including reporting adverse events and maintaining regulatory compliance.

marcel-scholte-LPurJnihmQI-unsplash.jpg

Contact Us:

Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn